The following data is part of a premarket notification filed by Behring Diagnostics, Inc. with the FDA for Emit Ii Opiates 300/2000 Assay.
Device ID | K971596 |
510k Number | K971596 |
Device Name: | EMIT II OPIATES 300/2000 ASSAY |
Classification | Enzyme Immunoassay, Opiates |
Applicant | BEHRING DIAGNOSTICS, INC. 3403 YERBA BUENA RD. P.O. BOX 49013 San Jose, CA 95161 -9013 |
Contact | David Kolesar |
Correspondent | David Kolesar BEHRING DIAGNOSTICS, INC. 3403 YERBA BUENA RD. P.O. BOX 49013 San Jose, CA 95161 -9013 |
Product Code | DJG |
CFR Regulation Number | 862.3650 [🔎] |
Decision | Substantially Equivalent (SESE) |
Type | Traditional |
3rd Party Reviewed | No |
Combination Product | No |
Date Received | 1997-05-01 |
Decision Date | 1997-06-25 |
Summary: | summary |
Device Identifier | submissionNumber | Supplement |
---|---|---|
00630414596105 | K971596 | 000 |
00630414568799 | K971596 | 000 |
00842768014338 | K971596 | 000 |
00842768001826 | K971596 | 000 |
00842768001819 | K971596 | 000 |